Modulation of natural killer activity by thymosin alpha 1 and interferon
- PMID: 3851698
- PMCID: PMC11038431
- DOI: 10.1007/BF00205574
Modulation of natural killer activity by thymosin alpha 1 and interferon
Abstract
A single injection of alpha beta-interferon (alpha beta-IFN) (30000 units/mouse), a major biological modifier of natural killer (NK) cytolytic activity, strongly stimulated NK activity in normal mice, as expected, while the same treatment did not statistically alter the NK response in cyclophosphamide (CY)-suppressed animals. We investigated the possibility of thymosin alpha 1 cooperating with alpha beta-IFN in boosting NK activity in CY-suppressed animals. The results show that treatment with thymosin alpha 1 (200 micrograms/kg) for 4 days, followed by a single injection of alpha beta-IFN 24 h before testing, strongly restored NK activity in CY-suppressed mice. Thymosin alpha 1 was, moreover, able to accelerate the recovery rate of NK activity in bone marrow reconstituted murine chimeras. Taken together the data support the concept that the synergic effect between thymosin alpha 1 and alpha beta-IFN could be the result of effects on differentiation of the NK lineage at different levels.
Similar articles
-
Combination treatment using thymosin alpha 1 and interferon after cyclophosphamide is able to cure Lewis lung carcinoma in mice.Cancer Immunol Immunother. 1990;32(3):154-60. doi: 10.1007/BF01771450. Cancer Immunol Immunother. 1990. PMID: 2126987 Free PMC article.
-
Synergistic effect of thymosin alpha 1 and alpha beta-interferon on NK activity in tumor-bearing mice.Int J Immunopharmacol. 1989;11(5):443-50. doi: 10.1016/0192-0561(89)90172-0. Int J Immunopharmacol. 1989. PMID: 2807622
-
Combined treatment with thymosin alpha 1 and interferon enhances NK activity in immunosuppressed tumor bearing mice.J Chemother. 1989 Jul;1(4 Suppl):1167-9. J Chemother. 1989. PMID: 16312818 No abstract available.
-
Effect of in vivo administration of prostaglandins and interferon on natural killer activity and on B-16 melanoma growth in mice.Cell Immunol. 1987 Apr 15;106(1):43-52. doi: 10.1016/0008-8749(87)90148-1. Cell Immunol. 1987. PMID: 3568147
-
Enhanced immune response and antitumor immunity with combinations of biological response modifiers.Bull N Y Acad Med. 1989 Jan;65(1):111-9. Bull N Y Acad Med. 1989. PMID: 2481523 Free PMC article. Review.
Cited by
-
Thymosin α1 activates complement receptor-mediated phagocytosis in human monocyte-derived macrophages.J Innate Immun. 2014;6(1):72-88. doi: 10.1159/000351587. Epub 2013 Jun 22. J Innate Immun. 2014. PMID: 23797159 Free PMC article.
-
Mechanism and clinical application of thymosin in the treatment of lung cancer.Front Immunol. 2023 Aug 28;14:1237978. doi: 10.3389/fimmu.2023.1237978. eCollection 2023. Front Immunol. 2023. PMID: 37701432 Free PMC article. Review.
-
Construction and Generation of a Recombinant Senecavirus a Stably Expressing the NanoLuc Luciferase for Quantitative Antiviral Assay.Front Microbiol. 2021 Oct 1;12:745502. doi: 10.3389/fmicb.2021.745502. eCollection 2021. Front Microbiol. 2021. PMID: 34659180 Free PMC article.
-
Immune therapy in sepsis: Are we ready to try again?J Intensive Care Soc. 2018 Nov;19(4):326-344. doi: 10.1177/1751143718765407. Epub 2018 Apr 4. J Intensive Care Soc. 2018. PMID: 30515242 Free PMC article. Review.
-
Combination treatment using thymosin alpha 1 and interferon after cyclophosphamide is able to cure Lewis lung carcinoma in mice.Cancer Immunol Immunother. 1990;32(3):154-60. doi: 10.1007/BF01771450. Cancer Immunol Immunother. 1990. PMID: 2126987 Free PMC article.
References
-
- Bardos P, Bach JF. Modulation of mouse natural killer cell activity by serum thymic factor. Scand J Immunol. 1982;15:321. - PubMed
-
- Bash JA, Woody JN, Neefe JR. NK Cells and other natural effector cells. New York: Academic Press; 1982. Phase I trial of immunomodulatory activities of human leukocyte interferon in advanced cancer patients; p. 1273.
-
- Bloom BR. Interferons and the immune system. Nature. 1980;284:593. - PubMed
-
- Djeu JY, Heinbaugh A, Holden HT, Herberman RB. Augmentation of mouse natural killer cell activity by interferon and interferon inducers. J Immunol. 1979;122:175. - PubMed
-
- Einhorn S, Blomgren H, Strander H. Interferon and spontaneous cytotoxicity in man. V. Enhancement of spontaneous cytotoxicity in patients receiving human leukocyte interferon. Int J Cancer. 1980;26:419. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources